TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Karo Pharma Norge AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 0 | 0 | 21 |
Financial expenses | 1,472 | 1,424 | 1,473 |
Earnings before taxes | 5,198 | 10,358 | 1,211 |
Total assets | 147,271 | 148,281 | 142,687 |
Current assets | 8,004 | 10,197 | 6,663 |
Current liabilities | 5,428 | 7,882 | 738 |
Equity capital | 117,971 | 112,010 | 106,737 |
- share capital | 27,735 | 33,759 | 26,979 |
Employees (average) | 0 | 0 | 0 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 80.1% | 75.5% | 74.8% |
Turnover per employee | |||
Profit as a percentage of turnover | 5766.7% | ||
Return on assets (ROA) | 4.5% | 7.9% | 1.9% |
Current ratio | 147.5% | 129.4% | 902.8% |
Return on equity (ROE) | 4.4% | 9.2% | 1.1% |
Change turnover | 0 | -21 | -40,601 |
Change turnover % | -100% | ||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.